JPRN-UMIN000008464Recruiting未知
Examination for the effect of eldecalcitol on muscle strength in primary osteoporotic patients - Effect of eldecalcitol on muscle strength
TT East Tohoku Hospital0 sites160 target enrollmentStarted: July 18, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 160
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 55years-old to 75years-old (—)
- Sex
- Female
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients with contraindication for bisphosphonate treatments 2. Patients with contraindication for eldecalcitol treatments 3. Patients who are treated with active vitamin D drugs within 8 weeks 4. Patients who have serum calcium levels of above 10.5mg/dL 5. Patients who are inappropriate for this study by physician
Investigators
Similar Trials
Completed
Not Applicable
Quantitative assessment of the eldecalcitol effect on intestinal calcium absorptioPrimary osteoporosisJPRN-UMIN000020267Research secretariat (IDD, Inc.)40
Not yet recruiting
Not Applicable
The effect of eldecalcitol on bone mineral density and bone markers for osteoporotic patients with type 2 diabetes.-Open label multicenter studyosteoporosisJPRN-UMIN000008417Shimane University Faculty of Medicine30
Not yet recruiting
Phase 4
Effect of Alfacalcidol on Muscle Function in Osteoporosis PatientsSarcopeniaNCT06272227Yonsei University340
Completed
Not Applicable
The effect of Eldecalcitol for glucocorticoid induced osteoporosis patients who are not recommended bisphosphonates therapyJPRN-UMIN000009589Department of Rheumatic Disease, Shinko Hospital40
Completed
Not Applicable
The additive effect of Eldecalcitol for glucocorticoid induced osteoporosis responding poorly to Alendronate.glucocorticoid induced osteoporosisJPRN-UMIN000009586Department of Rheumatic Disease, Shinko Hospital80